LCM
KRRO icon

Lynx1 Capital Management’s Korro Bio KRRO Stock Holding History

Lynx1 Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4M Buy
1,538,296
+860,381
+127% +$9.47M 2.75% 7
2025
Q4 		$5.43M Buy
+677,915
New +$15.8M 1.1% 10
2024
Q3 		– Sell
-3,800
Closed -$129K – 20
2024
Q2 		$129K Buy
+3,800
New +$210K 0.05% 16

Other funds holding KRRO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Lynx1 Capital Management's KRRO Position: Q1 2026 in Review

Lynx1 Capital Management increased its Korro Bio (KRRO) stake by 127% in Q1 2026, buying an estimated $9.47M and bringing the position to 1,538,296 shares worth $17.4M. The position accounts for 2.75% of the portfolio, ranked #7.

Lynx1 Capital Management first reported a position in KRRO in Q2 2024 and has held it in 3 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Lynx1 Capital Management held 1,538,296 shares of Korro Bio worth $17.4M as of Q1 2026.
  • Lynx1 Capital Management bought 860,381 Korro Bio shares in Q1 2026, an estimated $9.47M.
  • Korro Bio made up 2.75% of Lynx1 Capital Management's portfolio in Q1 2026, its #7 holding.
  • Lynx1 Capital Management first reported a position in Korro Bio in Q2 2024 and has held it in 3 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Lynx1 Capital Management's 13F filing for Q1 2026, filed 4 May 2026.